Q&A: What the Executive Order on Regulations Could Mean for EPA, FDA

A conversation with public health expert Lynn Goldman, a former assistant administrator at the US Environmental Protection Agency

Written byJoshua A. Krisch
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The headquarters of the United States Environmental Protection Agency in Washington, D.CWIKIMEDIA, COOLCAESERPresident Donald Trump signed an executive order on January 30, requiring that federal agencies repeal two regulations for every new one they propose. In a statement, Rick Pollack, chief executive officer of the American Hospital Association, praised the order as a step toward removing “red tape” that can drive up health care costs. Meanwhile, Joan Claybrook, former head of the National Highway Traffic Safety Administration, had a decidedly less optimistic reaction. “People are going to die if you start eliminating safety standards,” she told the Los Angeles Times.

Lynn Goldman, dean of the George Washington University Milken Institute School of Public Health and a former assistant administrator for the Environmental Protection Agency (EPA)’s Office of Chemical Safety and Pollution Prevention, spoke with The Scientist about the executive order, and the impact it may have on federal agencies including the EPA and the Food and Drug Administration (FDA).

The Scientist: What do you think was President Trump’s goal in issuing this order?

Lynn Goldman: I think his intent is to follow through on a commitment made in the campaign to reduce regulation, and I believe there was then a verbal commitment that, for every regulation issued, two would be eliminated. And, overall, there are many supporters of the president who sense the importance of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH